Cellular Metabolic Activity Marker Via Selective Turn-ON Detection of Transporter Protein Using Nitrobenzoxadiazole-based Fluorescent Reporter
Authors
Affiliations
A nitrobenzoxadiazole-based fluoroprobe (NBD-Bu) is designed to probe cellular metabolic activity in cancer and normal cells. NBD-Bu shows a significant fluorescence enhancement upon selective binding to the transport protein serum albumin in PBS buffer at ambient conditions. Encouraged by this finding, the site- specificity of NBD-Bu has been explored through a competitive displacement assay in the presence of site-specific markers such as warfarin and ibuprofen. Notably, even at micromolar concentrations, the probe possesses the ability to displace the site marker drug ibuprofen, efficiently. Subsequently, high-resolution fluorescence imaging results consolidated the potential of NBD-Bu for detection of abnormal cellular metabolic activity.
Benson S, Kiang A, Lochenie C, Lal N, Mohanan S, Williams G Theranostics. 2023; 13(11):3814-3825.
PMID: 37441588 PMC: 10334829. DOI: 10.7150/thno.84187.
Nanoparticulate Photoluminescent Probes for Bioimaging: Small Molecules and Polymers.
Lee S, Park C, Yoon H Int J Mol Sci. 2022; 23(9).
PMID: 35563340 PMC: 9100005. DOI: 10.3390/ijms23094949.
Silswal A, Kanojiya A, Koner A Front Chem. 2022; 10:840297.
PMID: 35360540 PMC: 8961804. DOI: 10.3389/fchem.2022.840297.
Biswas S, Dutta T, Silswal A, Bhowal R, Chopra D, Koner A Chem Sci. 2021; 12(28):9630-9644.
PMID: 34349935 PMC: 8293980. DOI: 10.1039/d1sc00542a.
Ogawa T, Sasaki A, Ono K, Ohshika S, Ishibashi Y, Yamada K Hum Cell. 2021; 34(2):634-643.
PMID: 33454890 PMC: 7900340. DOI: 10.1007/s13577-020-00483-y.